Search results
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 7 days agoOctober 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 2 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 6 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 5 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 4 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 6 days agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Johnson & Johnson (NYSE:JNJ) Shares Sold by CNB Bank
ETF DAILY NEWS· 4 days agoCNB Bank reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange ...
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
Fox News· 5 days agoThe Radiation Exposure Compensation Act has been a lifeline for some people and families exposed to...
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
Morningstar· 15 hours agoNEW YORK, April 29, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering